The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations that increased transmissibility or helped the virus evade our immune ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

Having this knowledge from our model would help with readiness for detecting ... SARS-CoV-2 variants with human host cells, Momeni said. The spike protein of the coronavirus, or SARS-CoV-2, binds to ...

Researchers have developed a powerful tool that can detect variants of SARS-CoV-2 with high transmission potential before ... Subscribe for FREE Many of these key mutations are in the spike protein, ...

In December 2024, a rumor began spreading online that a team of researchers at Yale University had found the "spike protein" of the SARS-CoV-2 virus, which is responsible for the COVID-19 illness ...

such as those for the spike protein, inserting the blueprints into DNA, RNA or a safe virus and injecting those into people. The Remarkable and Mysterious Coronavirus Genome The SARS-CoV-2 genome ...

It is important to understand the correlates of protection against SARS-CoV-2 and its variants for future vaccine design. Here, the authors show that the complement system enhances the antibody ...